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Abstract: High resolution Fourier transform mass spectrometry (HRFTMS) and nuclear 
magnetic resonance (NMR) spectroscopy were employed as complementary metabolomic 
tools to dereplicate the chemical profile of the new and antitrypanosomally active  
sponge-associated bacterium Actinokineospora sp. EG49 extract. Principal Component 
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(PCA), hierarchical clustering (HCA), and orthogonal partial least square-discriminant 
analysis (OPLS-DA) were used to evaluate the HRFTMS and NMR data of crude extracts 
from four different fermentation approaches. Statistical analysis identified the best culture 
one-strain-many-compounds (OSMAC) condition and extraction procedure, which was 
used for the isolation of novel bioactive metabolites. As a result, two new O-glycosylated 
angucyclines, named actinosporins A (1) and B (2), were isolated from the broth culture of 
Actinokineospora sp. strain EG49, which was cultivated from the Red Sea sponge 
Spheciospongia vagabunda. The structures of actinosporins A and B were determined by 
1D- and 2D-NMR techniques, as well as high resolution tandem mass spectrometry. 
Testing for antiparasitic properties showed that actinosporin A exhibited activity against 
Trypanosoma brucei brucei with an IC50 value of 15 µM; however no activity was detected 
against Leishmania major and Plasmodium falciparum, therefore suggesting its selectivity 
against the parasite Trypanosoma brucei brucei; the causative agent of sleeping sickness. 
Keywords: actinosporins; Spheciospongia vagabunda; Actinokineospora; anti-trypanosomal; 
dereplication; secondary metabolomics 
 
1. Introduction 
Dereplication refers to the rapid identification of known secondary metabolites and their 
quantification in crude unfractionated extracts [1–3]. This can be a demanding undertaking, because 
secondary metabolites occur in a wide range of concentrations along with enormous variations in their 
chemical and physical properties. Therefore, reliable, robust, and selective analytical methods are 
required to identify secondary metabolites in complex mixtures. To date, LC-UV/MS signatures have 
been successfully used with AntiBase and MarinLit databases [4]. Owing to the superior sensitivity of 
mass spectrometry and reproducibility of NMR spectroscopy, they are suitable complementary analytical 
tools for natural products identification. The large data set produced by NMR and MS experiments 
requires multivariate analysis for data interpretation, such as principal component analysis (PCA), 
hierarchical clustering analysis (HCA), and orthogonal partial least square-discriminant analysis  
(OPLS-DA) [5]. Application of these analytical and statistical methods in metabolomics, facilitates the 
discovery of potentially novel microbial secondary metabolites as well as the bioassay-guided isolation 
work [1,2,6–12]. As an example, Hou and co-workers [13] employed untargeted secondary 
metabolomics using LC/MS-PCA as an effective strategy for strain prioritization to yield the most 
chemically diverse and novel natural products for drug discovery. Metabolomics is not yet widely 
applied as a natural product screening tool, although it has several advantages over the classical 
bioassay-guided isolation approach. By using combinations of different analytical methods, the 
bioassay-guided isolation route is shortened and putative identification of potentially new natural 
products is rapidly achieved [3,14]. 
Actinomycetes are frequently isolated from different marine, filter-feeding invertebrates, including 
sponges, corals, tunicates, and jellyfish [15–19]. Marine actinomycetes are still an underexplored 
source of secondary metabolites and lead molecules with biotechnological, therapeutic, and industrial 
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applications [20,21]. Metabolites from these microorganisms were shown to exhibit diverse activities, 
such as antibacterial, antifungal, antiparasitic, immunomodulatory, anti-inflammatory, anti-protease, 
antioxidant, and anticancer activities [22–25]. These activities are mediated by several classes of 
natural products, including polyketides, alkaloids, peptides, and terpenes [26–29]. Members of the 
genus Actinokineospora have been cultivated from terrestrial soils and plants [30,31], and were 
recently isolated for the first time from a marine sponge [32]. This rare genus is not yet known for the 
production of secondary metabolites. 
Angucyclines are a large family of actinomycete-derived polyketide antibiotics with a four-ring 
skeleton that constitutes the aglycone part [33,34]. Structurally, angucyclines consist of a 
benzanthraquinone core, which is usually C- or O-glycosylated with sugar chains of various lengths, 
including the three main sugar moieties: olivose, rhodinose, and amicetose, such as rabelomycin and 
landomycins families (e.g., landomycin P) [35,36]. Angucyclines showed diverse activities, including 
antitumor, antibacterial, inhibition of platelet aggregation, and enzyme inhibitory activities [37,38]. 
They were isolated from bacterial genera, such as Amycolatopsis and Nocardia, and frequently from 
the genus Streptomyces [39–41], such as most recently from the deep sea sediment-derived 
Streptomyces lusitanus SCSIO LR32 [42]. 
Figure 1. Work flowchart. 
 
The goal of this work was to implement untargeted secondary metabolomics in the dereplication  
of crude extracts of Actinokineospora sp. EG49 [32] that displayed antitrypanosomal activity. Our 
approach was two-pronged (Figure 1). First, we aimed to optimize the production of the antitrypanosomal 
metabolites by the ―one-strain-many-compounds‖ (OSMAC) approach [43]. The dereplication strategy 
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employed both MS and NMR to cross validate and quantify the bioactive metabolites in four different 
fermentation approaches: ISP2 agar, ISP2 liquid broth, ISP2 liquid broth with XAD-16, and ISP2 
liquid broth with calcium alginate beads, as well as between two different extraction procedures. 
Secondly, we aimed to identify putative novel bioactive compounds from the strain EG49. 
2. Results and Discussion 
2.1. Metabolomic Profiling of the Crude Ethyl Acetate Extract of ISP2 Agar Culture of EG49 
The crude ethyl acetate extract of ISP2 agar culture of Actinokineospora sp. EG49 isolate exhibited 
100% growth inhibition of Trypanosoma brucei brucei S427 at a concentration of 20 µg/mL. This 
prompted us to perform further chemical work on this bioactive isolate. We used two independent 
approaches: metabolomics-guided optimisation of the production of the biologically active component 
and, in parallel, bioassay-guided isolation of the active principle. Dereplication of the secondary 
metabolites from the antitrypanosomally active isolate Actinokineospora sp. strain EG49 was achieved 
by high resolution Fourier transform mass spectrometry (HRFTMS) using the Exactive-Orbitrap and 
high resolution NMR. Secondary metabolites were tentatively identified with the aid of existing high 
resolution MS and NMR records from online and in-house databases, i.e., MarinLit, a database for 
marine natural products and AntiBase, a database of microbial secondary metabolites. The software 
tools MZmine 2.10 [44,45] and SIMCA 13.0.2 were utilized to perform differential analysis of sample 
populations to find significantly expressed features relating to complex biomarkers between parameter 
variables. Only Antibase and Marinlit databases were employed in this study for a more practical 
discriminatory search of taxonomically-related microbial metabolites. The limitation of a dereplication 
study for secondary metabolites, particularly from marine sources, is the difficulty to attain a reference 
standard for every found ―hit‖ from the database. To ensure the correctness of the identification of the 
basic structure of the identified peaks, UV, MS/MS data, and NMR spectral data were used to support 
the results. These combinatory methods of identification were more reliable than utilizing MS/MS  
data alone for which no global library is available to this date. MS/MS data are highly dependent on 
various parameters, such as source settings and potential differences between the skimmers as well as 
between instruments. 
Prior to dereplication, molecular formula prediction was done utilizing MZmine’s algorithm, which 
employs a combination of empirical techniques that included isotope pattern matching [44]. Using the 
positive and negative mode electrospray ionization spectral data at a MW tolerance within 5 ppm, 
known compounds were tentatively identified with AntiBase and MarinLit. Most of the identified 
compounds were previously isolated from the genus Streptomyces (Supplementary Information,  
Table S1). The identified compounds are highlighted in the total ion chromatogram showing the 
distribution of the known and unknown compounds (Figure 2). The known compounds detected from 
the dereplication study are shown in Figure 3. The anthraquinone structure was identified from their 
typical UV spectrum as well as through the 
13
C NMR spectral data of the crude extract where signals 
were observed between 160 and 200 ppm (see Supplementary Information, Figure S1). As previously 
observed by Nielsen’s group [12], the negative mode revealed the presence of a variety of quinone 
compounds (9–18, 20–24) (Figure 3). From the unidentified peak list, as shown in Supplementary 
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Information, Table S2, new quinone congeners were detected and the molecular formula prediction, 
the double bond equivalence, and MS
n
 data are summarized in the table. The MS
2
 and/or MS
3
 data 
revealed a glycosidic fragment of 146 Da, while MS
3
 fragment gave a Ring Double Bond (RDB) of 14 
for the anthraquinone core (see Supplementary Information, Figure S2 for the mass spectral data and 
Table 1 for a brief illustration of the MS/MS fragmentation for the most intense chromatography 
peaks). The MS fragmentation experiments confirmed the presence of gylcosidic angucyclines and 
new compounds against those found in the database. One example is elloramycin E, which is also an 
anthraquinone congener with just one sugar unit. However, the loss of two 146 Da [C6H10O4] units 
does suggest that the structure is a glycosidic angucycline congener.  
Figure 2. Total ion chromatogram of crude ethyl acetate extract of Actinokineospora sp. 
EG49 ISP2 agar culture in both positive (blue line) and negative (red line) modes. The 
chromatogram was an output generated from MZmine; a high-throughput differential 
expression analysis software, which provides algorithms for peak alignment, 
normalization, and deconvolution. The resulting data sets were then subjected to  
automated dereplication.  
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Figure 3. Compounds identified and dereplicated from high resolution mass spectral data 
sets of the crude ethyl acetate extract of Actinokineospora sp. EG49 ISP2 agar culture of by 
utilizing macros and algorithms that coupled MZmine with both in-house and commercial 
databases. (Some stereocenters were not assigned due to the presence of other 
stereoisomers found in the database. As shown in Figure 2, peaks 7 and 8 at different 
retention times gave the same ―hit‖ compound, which were then numbered accordingly, 
indicating the possibility of chemical isomers for either peaks. Stereocenters were drawn as 
found in the database.) 
 
The presence of anthraquinones was confirmed by UV and NMR spectral data. From the 
photodiode array (PDA) detector, UV-Vis spectra of individual peaks identified as quinones displayed 
four transitions above 240 nm with three more intense bands near 250, 270, and 320 nm for a 
benzenoid and quinonoid moiety, respectively. On the other hand, NMR showed the presence of 
resonances between 12 and 13 ppm, representing the hydrogen-bound phenolic hydroxyl on the 
carbonyl group. Quinone analogues have been reported to have antitrypanosomal activity; the 
inhibitory mechanism of which is assumed to be the induction of oxidative stress against trypanothione 
reductase, a key enzyme involved in the trypanosomal antioxidant thiol metabolism [46]. Therefore, 
quinone compounds may contribute to the antitrypanosomal activity of EG49 ISP2 agar extract. 
It is clear from the chromatogram that more than half of the peaks were not identified by 
comparison with the databases, including some of the major components that showed strong peak 
intensities and good resolution. The m/z value and the predicted formula of these unidentified 
compounds are presented in Supplementary Information, Table S2. The high number of unidentified 
compounds highlights the chemical potential of this strain as a source of new metabolites. 
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Table 1. MS/MS fragmentation of major peaks found in the total ion chromatogram of the 
crude ethyl acetate extract of Actinokineospora sp. EG49 ISP2 agar culture in the negative 
ionization mode.  
RT min [M − H]− Predicted MF [M − H]− [M − ADDUCT]− MS2 MS3 
8.10 
513.1398 
14 RDBE 
C26 H25 O11  
  
Atramycin A (12) 
467.13 
[M − HCOOH] 
C25 H23 O9 
321.08 
[−C6 H10 O4] 
C19 H13 O5 
13 RDBE 
 
 
8.97 
657.1822 
16 RDBE 
C32 H33 O15 
  
Actinosporin A (1) 
611.18 
[M − HCOOH] 
C31 H31 O13 
465.12 
[−C6 H10 O4] 
C25 H21 O9 
 
319.06 
[−C6 H10 O4] 
C19 H11 O5 
14 RDBE 
 
9.85 
641.1875 
16 RDBE 
C32 H33 O14  
Unknown 
595 
[M − HCOOH] 
C31 H31 O12 
451.14 
[−C6 H10 O4] 
C25 H23 O8 
14 RDBE 
305.08 
[−C6 H10 O4] 
C19 H13 O4 
13 RDBE 
10.60 
657.1826 
16 RDBE 
C32 H33 O15 
Elloramycin E * 
  
* Elloramycin E not 
possible due to loss of 
two sugar units. 
611.18 
C31 H31 O13 
Unknown 
465.12 
[−C6 H10 O4] 
C25 H21 O9 
15 RDBE 
319.06 
[−C6 H10 O4] 
C19 H11 O5 
14 RDBE 
15.37 
467.1353 
14 RDBE 
C25 H23 O9 
  
BE-12406-A 
 
320.07 
[−C6 H10 O4] 
C19 H12 O5 
14 RDBE 
 
291.07 
[−OCH3] 
C18 H11 O4 
13 RDBE 
 
15.98 
465.1191 
15 RDBE 
C25 H21 O9  
  
Galtamycinone 
449.12 
[−O] 
C25 H21 O8 
 
319.06 
[−C6 H10 O4] 
C19 H11 O5 
14 RDBE
 
303.07 
[−OH] 
C19 H11 O4 
14 RDB
 
  
Mar. Drugs 2014, 12 1227 
 
 
2.2. Metabolomic Profiling of Cellular and Supernatant Extracts from Liquid Broth Cultures of EG49 
Metabolomic profiling was performed on methanol and acetone cellular extracts of three cell pellets 
and ethyl acetate extracts of their respective culture supernatants along with an extract obtained from 
the solid agar medium, as acquired from the cultivation protocol. The MS data were subjected to 
statistical analysis. PCA was then used to determine the differences of the extracts obtained from 
various culture conditions and extraction procedures. The degree of similarity between the ethyl 
acetate supernatant extracts from the four different culture media was higher than those of the 
methanol and acetone cellular extracts, which exhibited more dispersed and distinct features, as shown 
from the OPLS-DA map (Figure 4A). An S-plot was primed from the OPLS plot to determine the ―end 
point‖ compounds, which define unique secondary metabolomes that differentiates the supernatant 
from the cellular extracts (Figure 4B and Table 2). Different sets of metabolites were extracted by the 
respective solvents, but with more anthraquinone derivatives being extracted from the supernatant with 
ethyl acetate than from the cells with acetone and methanol (Table 2). 
Figure 4. Orthogonal partial least square-d iscriminant analysis (OPLS-DA) (A) and S-plot 
(B) of supernatant (red) vs. cellular extracts (blue). S (solid); LE (liquid ethyl acetate); LM 
(liquid methanol); BE (beads ethyl acetate; BM (beads methanol); XE (XAD ethyl acetate); 
XA (XAD acetone). R2 = 0.931, Q2 = 0.995 for OPLS-DA map. 
  
(A) (B) 
Table 2. The ―end point‖ compounds defined as unique metabolites for every group, as 
shown on the S-plot in Figure 4B. (P = positive mode; N = negative mode). 
Solvent Ionisation Mode MS m/z Rt (min) Chemical Formula Name 
EtOAc N 467.1350 8.27 C25H24O9 Atramycin A (12) 
EtOAc P 469.1494 8.28 C25H24O9 Atramycin A (12) 
EtOAc N 513.1404 8.28 C26H25O11 Unknown 
EtOAc N 611.1768 8.98 C31H32O13 (new) * Actinosporin A (1) 
EtOAc N 657.1828 10.50 C32H34O15 Elloramycin E (10) 
EtOAc N 501.1407 10.76 C25H26O11 (new) * Actinosporin B (2) 
EtOAc N 467.1350 15.13 C25H24O9 BE-12406-A 
EtOAc N 449.1247 15.97 C25H22O8 Galtamycinone 
MeOH N 377.0860 1.38 C15H9O3N10 Unknown 
MeOH N 452.2787 21.50 C25H40O7 Unknown 
* Structures shown in Figure 5. 
Supernatant 
Cell 
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Figure 5. Structures of actinosporins A (1) and B (2). 
  
(1) (2) 
The extraction pattern was validated by subjecting the NMR spectral data (Figure 6A shows the 
scatter plot of NMR spectral data) to PCA (Figure 6C shows the 3D PCA-score plot and PCA-loading 
plot, respectively) and line plot (Figure 6D) obtained from the hierarchical clustering analysis 
(Figure 6E) of the PCA results performed on the NMR spectral data). Figure 6A indicated the presence 
of anthraquinone compounds to be highly concentrated in ISP2 broth with alginate beads, as shown by 
the dominance of red triangles (▲ = BE) at ca. 7.25 ppm, depicting aromatic proton signals on the 
anthraquinone moiety. The PCA results gave significant scores of 1.0 and 0.961 for cumulative R2X 
and Q2, respectively, which implied a very good prediction model for the variables. The 3D score plot 
of the different culture extracts showed the cellular XAD-acetone extract as an outlier, whilst the solid 
agar extract clustered with the methanolic cell extracts (Figure 6B). This could be explained by the 
different experimental procedures, where the cells were not separated from the agar media prior to 
extraction in contrast to those of the broth media. Line plots of the hierarchical clustering analysis 
(HCA) data (Figure 6E) revealed that the methanolic cellular extracts only contained primary polar 
metabolites (Figure 6D), which were mostly saccharides, as represented by the chemical shifts at  
ca. 5.0 ppm and between 3.0 and 4.0 ppm. The signals from the ethyl acetate extracts showed a more 
even distribution of resonances between 1.0 and 8.5 ppm in comparison to the methanolic extracts.  
The presence of signals between 3.0 and 5 ppm signified the presence of sugar moieties in the structure 
of metabolites found in the supernatant. The distribution of chemical shifts was reflected in the line 
plot (Figure 6D) obtained from the HCA dendrogram in Figure 6E. The aromatic region was 
dominated by signals belonging to the ethyl acetate supernatant fractions, which confirmed the 
presence of glycosidic quinone congeners in conformity with the dereplication study on the mass 
spectral and mass fragmentation data. The PCA and OPLS-DA of both the NMR and mass spectral data 
(Figures 3 and 4) consistently showed that the secondary metabolites of interest were secreted into the 
media. These results highlight the chemical diversity of the supernatants over the cell pellets in 
Actinokineospora sp. EG49 cultures. 
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Figure 6. NMR-based dereplication of EG49 extracts: (A) Scatter plot of NMR spectral 
data (S; LE; LM; ▲BE; ▼BM; XE; XA); (B) 3D Principal component analysis 
(PCA)-score plot; (C) PCA-loading plot of cellular (blue) vs. supernatant extracts (red); 
(D) Line plots obtained from the hierarchical clustering analysis of the PCA results as 
shown in (E). The primary observed ID (obs ID) is synonymous to the chemical shift in ppm. 
  
(A) (B) 
  
(C) (D) 
 
(E) 
2.3. Quantification of Actinosporin A in Four Different Culture Media 
To optimize production of the biologically active metabolites, dereplication was performed for 
microbial extracts prepared in triplicates obtained from four different growth media strategies (ISP2 
agar, ISP2 broth, ISP2 broth with XAD, and alginate beads), as shown in Figures 7 and 8. Through the 
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scatter- and S-plots (Figure 7), it was shown that unique metabolites were produced in respective 
culture media. The active antitrypanosomal compound actinosporin A (m/z 611.1768 [M − H]−) with 
retention time at 8.98 min was shown to be produced at the highest yield in liquid broth (LE) and 
alginate beads (BE) media (Figure 8), while it was produced in negligible amounts when XAD (XE) 
was used. There was a significant decrease of probable quinone congeners in the XAD media, which 
was indicated by the disappearance of dispersed components (represented by yellow dots) in the upper 
region of the diagonal for the ISP2 XAD extract when comparing the MZmine scatter plots in 
Figure 7A,B with Figure 7C. 
Figure 7. Scatter plot (A–D, MZmine 2.10) and S-plot (D, E, SIMCA 13) of the mass 
spectral data for EG49 ethyl acetate extracts obtained from different culture methods. For 
the MZmine scatter plots on (A–C), dots nearer to or on the diagonal lines represent 
metabolites commonly found in both culture media, while the unique metabolites for each 
respective media appear above or below the diagonals on the direction of the respective 
axis representing each of the culture media. For the S-plots on (D–F), metabolites 
emerging at the center of the XY axis are the common metabolites for both media, while 
the unique metabolites for the respective medium are observed at the ―end-points‖ of the 
sigmoidal curve. Probable quinone congeners eluting between 5 and 30 min are marked 
yellow on the scatter plots. The ion at m/z 611.177 with retention time of 8.98 min 
representing the antitrypanosomal active compound 1 is encircled in red.  
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Figure 7. Cont. 
  
(C) (F) 
Figure 8. Scatter plots of the dereplicated mass spectral data of EG49 crude extracts 
obtained from four different growth media: S = ISP2 agar, LE = ISP2 broth, BE = calcium 
alginate beads, and XE = ISP2 broth with XAD. Inset shows the contribution of 
actinosporin A in different culture media and extracts.  
 
Analyzing the yield of ethyl acetate extract in % w/v, ISP2 with calcium alginate bead (BE) gave 
the highest yield of 29.2%, followed by ISP2 agar (S) with 11.9% and ISP2 broth (LE) with 8.9%, 
while ISP2 with XAD (XE) showed the lowest yield of only 7.3% with extraction efficiencies of 
79.9% for BE, 41.8% for LE, and 35.6% for XE. In terms of the production of the antitrypanosomal 
active metabolite, as shown in Figure 8, the best concentration can be achieved at approximately 
1.0E08 ion abundance, using either ISP2 broth (LE) or ISP2 with calcium alginate beads (BE). ISP2 
with calcium alginate beads (BE) afforded higher biomass, but the ISP2 broth (LE) offered a more 
ISP2-XAD 
(-)611.177 
 
ISP2 Agar 
 
(-)611.177 
 
ISP2 Agar 
 
ISP2-XAD 
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diverse range of interesting congeners, as shown in Figure 7A from the increase in the dispersal of the 
metabolomes on the Y axis for the ISP2 broth extract. 
2.4. Bioassay-Guided Isolation and Structure Elucidation of the New Actinosporins A and B 
Crude extracts of the Actinokineospora sp. EG49 strain obtained from four fermentation approaches 
were tested against T. brucei brucei. Among all extracts, the ethyl acetate extract from the ISP2 broth 
culture (LE) was the most active and, therefore, was selected to pursue bioassay-guided isolation of the 
bioactive metabolites. The antitrypanosomally active ethyl acetate extract was chromatographed on 
silica gel by gradient elution with CHCl3 and MeOH. Fractions exhibiting a growth inhibition of  
T. brucei brucei of more than 50% were considered active and subjected to further isolation work  
(see Figure S3 in Supplementary Information for schematic diagram). The bioactive semi-polar 
fraction eluting with 60:40 of CHCl3:MeOH was further subjected to gel filtration on Sephadex LH-20 
by gradient elution with MeOH:H2O, commencing with 20% MeOH culminating to 100% MeOH. The 
LH-20 fraction eluting at 60:40 MeOH:H2O exhibited antitrypanosomal activity and final purification 
was accomplished on reversed-phase HPLC to yield two pure compounds 1 and 2, named 
actinosporins A and B, respectively (Figure 5). Actinosporin A showed a molecular formula of 
C31H32O13 by HR-ESIMS (ORBITRAP) analysis (found at m/z 613.1915 [M + H]
+
), with 16 degrees of 
unsaturation. HRFT-tandem MS of the molecular ion peak at m/z 611.1768 [M − H]− for C31H31O13 
gave fragment ion peaks at m/z 465.1177 (C25H21O9, calcd: 465.1186) and 319.0607 (C19H11O5,  
calcd: 319.0601), and revealed the successive loss of two saccharide units, since the subtracted 
molecular formula was C6H11O4. This molecular ion peak at m/z 611.1768 was also found in the above 
list of unidentified compounds during the dereplication study. The presence of two anomeric protons at  
δH 5.48 and 5.66 along with 2 methyl doublets in the aliphatic region indicated the presence of two  
6-deoxy rhamnose moieties and further confirmed the characteristic chemical shifts for the anomeric 
carbons at 99.0 and 99.6 ppm, which suggested the glycosidic nature of the compound. The IR 
spectrum showed bands at 3389, 3206, 1677 cm
−1
, thus indicating the possible occurrence of carbonyl 
and hydroxyl functionalities. 
The 
1
H-
1
H-COSY spectrum indicated two substructures, along with one methine at δH 7.69  
that appeared as a singlet. The first substructure involved two doublets at δ 7.21 (J = 7.3 Hz) and 7.52 
(J = 7.3 Hz) ppm, and an apparent triplet at δ 7.66 (J = 7.3 Hz), which can be attributed to a  
1,2,3-trisubstituted aromatic system. The second substructure consisted of two meta-coupled aromatic 
protons at δH 7.19 and 7.26. A singlet of an aromatic-bound methyl group was observed at δH 2.47, 
which coupled to the two meta-coupled aromatic resonances. The 
13
C NMR spectrum displayed two 
quinone carbonyls (δC 186.2 and 187.5), two anomeric carbons (δC 99.0 and 99.6), eight oxymethine 
carbons (δC 69.6, 69.9, 70:4, 70.6, 70.7, 70.9, 72.4, 72.5), three tertiary carbinols (δC 152.3, 153.9, 
161.2), five shielded sp
2
 methine carbons (δC 112.2, 116.9, 117.1, 119.6, 122.6), and a distinct signal at 
δC 20.8 consistent for an aromatic methyl. Analysis of the COSY, HSQC, and HMBC data (Table 3) 
showed that the core of the compound had a benz(α)anthraquinone backbone, which is characteristic 
for the angucycline group. ROESY (rotating-frame nuclear Overhauser effect correlation 
spectroscopy); and HMBC revealed that the two sugars were O-linked to the aglycone at C-1 (
3
JC-H 
correlation between δH-1′ 5.48 with δC-1 153.9) and the other at C-6 (
3
JC-H correlation between H-1′′,  
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δH-1 5.66 with C-6, δC 152.3). In addition, ROESY correlations were detected between H-1′ and H-2, 
as well as between H-1′′ and H-5, confirming the glycosidation at C-1 and C-6, respectively. COSY 
data deduced the spin systems for the two rhamnose moieties. The two anomeric protons of the two 
sugars appeared as broad singlets, indicating that the anomeric configuration of the two sugar moieties 
were α-glycosidically linked. Further confirmation of the equatorial orientation of the anomeric 
protons on the two rhamnose residues was established via measurement of the one-bond 
13
C–1H 
couplings (
1
JCH). In a 
13
C-coupled HSQC experiment, the 
1
JCH for the two anomeric protons resonating 
at δH 5.48 and 5.66 were found to be 172.1 and 172.9 Hz, respectively, consistent with an  
α-configuration. The relative configuration of the rhamnose residues in 1 was determined by their 
coupling constants and ROESY data at 600 MHz with tm = 400 ms. For sugar A, the large coupling 
constant for the proton H-4′ (J = 9.4 Hz), resulting from diaxial correlations, showed that H-3′, H-4′, 
and H-5′ had axial orientations. Furthermore, the small coupling constant between H-3′ and H-2′  
(J = 3.4 Hz) showed that H-2′ was oriented equatorially. Thus, 1H NMR coupling constant analysis, 
COSY and ROESY experiments showed that compound 1 consists of L-rhamnose, which is the 
naturally occurring isomer among natural products. The relative configuration of sugar B was the same 
as sugar A, based on the same spectroscopic information. Acid hydrolysis of 1 was performed to  
yield L-rhamnose, which was confirmed via TLC and comparison to authentic samples. Based on  
the detailed analysis of the NMR spectra, the structure of compound 1 was determined to be  
8-hydroxy-3-methylbenz[α]anthracene-7,12-dione-1-O-α-L-rhamnopyranose-6-O-α-L-rhamnopyranoside, 
which had not been previously reported. It was designated the trivial name actinosporin A. 
Table 3. NMR data of actinosporin A (1), measured in CD3OD-d4 (
1
H: 600 MHz;  
13
C: 150 MHz). 
Position C/H No. δH, Mult (J in Hz) COSY δC Mult HMBC (δH to δC) ROESY 
1   153.9 C   
2 7.19, s  H-3-CH3 112.2 CH 
C-1, C-3, C-3-CH3, 
C-4, C-12a, C-12b 
H-3-CH3, 
H-1A 
3   142.0 C   
3-CH3 2.47, s H-2, H-4 20.8 CH3 C-2, C-3, C-4  
4 7.26, s H-3-CH3 119.6 CH 
C-2, C-3-CH3,  
C-4a, C-12b  
H-3-CH3, 
H-5 
4a   138.9 C   
5 7.69, s  116.9 CH 
C-4, C-6, C-6a,  
C-12b 
H-4, H-1B, 
H-5B 
6   152.3 C   
6a   124.0 C   
7   186.2 C   
7a   115.7 C   
8   161.2 C   
9 7.21, d (7.3) H-10, H-11 122.6 CH C-7a, C-11, C-10  
10 7.66, t (7.3) H-9, H-11 136.1 CH C-8, C-11, C-11a  
11 7.52, d (7.3) H-9, H-10 117.1 CH 
C-7, C-7a, C-9,  
C-10, C-12 
 
11a   135.5 C   
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Table 3. Cont. 
12   187.5 C   
12a   140.0 C   
12b   116.1 C   
1′ 5.48, brs H-2′ 99.6 CH C-1, C-2′, C-5′ H-2 
2′ 4.05, s H-1′, H-3′ 70.4 CH C-3′, C-4′  
3′ 
3.80, dd  
(9.4, 3.4) 
H-2′, H-4′ 70.9 CH C-4′, C-5′  
4′ 3.48, t (9.4) H-3′, H-5′ 72.4 CH C-3′, C-5′, C-6′ H-6′ 
5′ 3.76, m H-6′ 69.6 CH C-6′ H-3′ 
6′ 1.25, d (6.3) H-5′ 16.5 CH3 C-5′, C-4′  
1″ 5.66, brs H-2″ 99.0 CH C-8, C-5″, C-4″ H-5 
2″ 4.22, d (3.4) H-1″, H-3″ 70.6 CH C-3″, C-4″  
3″ 4.25, s H-2″, H-4″ 70.7 CH C-4″ H-5″ 
4″ 3.53, t (9.2) H-3″, H-5″ 72.5 CH C-2″ C-3″, C-6″  
5″ 3.74, m H-6″ 69.9 CH C-3″, C-4″, C-6″  
6″ 1.27, d (6.2) H-5″ 16.6 CH3 C-4″, C-5″  
Note: s (singlet); d (doublet); t (triplet); brs (broad singlet). 
Actinosporin B was obtained as an orange oil and the mass spectrum revealed the occurrence of  
m/z 501.1402 in negative mode and m/z 503.1554 in positive mode (C25H26O11). This pseudomolecular 
ion peak was found in the identified compounds list (Table 1) and the structure of 2 was studied by 
comparing the mass spectral and NMR data with the known compound hit 13, which was found in 
AntiBase and proved that the isolated compound was different from compounds reported in the 
literature. It was of interest to us to elucidate this compound due to its exclusive occurrence in the ISP2 
solid agar extract only. 
The UV spectrum exhibited a maximum absorption at 254 nm, while a shift of the bands from 310 
to 379 nm indicated loss of aromaticity on Ring A. The 
1
H NMR spectrum showed the presence of 
aromatic protons with peaks from δH 7.62 to 7.96, which all integrated for one proton each. The COSY 
spectrum revealed two spin systems in the aromatic region. Correlation between the ―pseudo-triplet‖ at 
δH 7.86 and two doublets at δH 7.96 and 7.71 indicated an ABC spin system. The correlation of two 
ortho-coupled doublets at δH 7.80 and 7.62 suggested an AB aromatic spin system. The parent 
structure was determined to be a quinone with one aromatic ABC system (ring D) and another AB 
system (ring B). The presence of a rhamnose unit was also detected from the COSY spectrum with the 
characteristic methyl 6.3 Hz doublet at δH 1.10, which correlated with a proton at δH 3.53 as well as the 
broad singlet at δH 5.65, resulting in a cross peak with a signal at δH 3.35. Attachment of the rhamnose 
was deduced to be on C-8 as the proton doublet at C-9 was highly deshielded, as observed in similarly 
substituted analogues, such as landomycin and atramycin. 
Two well-resolved geminal methylene doublets at δH 3.01 and 2.90 with 
2
J of 13.4 Hz were 
assigned at position 4 due to the benzylic nature of the deshielded chemical shifts as well as their being 
adjacent to a stereogenic center at C-3. The hydroxyl methylene protons H-13A and H-13B situated on 
the quaternary chiral carbon C-3A were assigned to the broad doublet signal at δH 4.93 coupling with 
its germinal partner proton found underneath the solvent peak at δH 3.35 as determined by COSY. The 
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hydroxylated broad methine doublet at δH 5.12 correlated with the broad singlet peak at δH 4.01 and 
were assigned to be H-1 and H-2, respectively. For a small yield of less than 1 mg, 
1
H-
1
H-COSY, 
HSQC/HMQC and HMBC NMR spectral data were collected. However, the HSQC and HMQC did 
not give any good resolution for further data interpretation. Partial carbon assignments can be deduced 
from the HMBC data. The methylene doublets at δH 3.06 and 2.90 for H-4A and H-4B on ring A 
correlated with carbon signals at δC 71.7, 72.5, 116.0 133.3, and 140.7 for positions 2, 3, 12b, 12a 
(
4
Jω), and 4a respectively, further indicating the loss of unsaturation on ring A. On the other hand, the 
ortho doublet at δH 7.62 for H-5 on ring B exhibited cross peaks with δC at 42.7, 116.0, 133.3, and 
181.0 (
4
Jω), for positions 4, 12b, 6a, and 7, respectively. On ring D, cross peaks were observed 
between the ortho doublet at δH 7.70 for H-9 and δC at 122.0 for C-11. The ortho triplet at δH 7.87 for 
H-10 had a correlation with δC at 135.6 for C-11a and 156.9 for C-8. The 4 ppm upfield shift of C-8 in 
comparison to compound 1 was additional evidence on the attachment of rhamnose on ring D which 
was also further confirmed by the correlation of the anomeric proton at δH 5.65 with δC 156.9. The 
methyl doublet at δH 1.10 had cross peaks with the oxymethine carbons at δC 71.4 (C-3′) and  
71.5 (C-4′), while the anomeric proton correlated with signals at δC 70.5 (C-2′) and 64.0 (C-5′). 
High resolution FT tandem MS was performed obtaining a fragment ion at m/z 399.1079  
[M − C4H6O3]
−
 which implied a cross-ring cleavage comparable to a glycan unit [47] and confirmed 
the presence of a highly hydroxylated saturated ring A. High resolution mass spectral data of the 
fragment ions verified the presence of four hydroxyl substituents on ring A as shown in Figure 9.  
Further fragmentation of the ion at m/z 399.1079 afforded an ion peak at m/z 253.0502 indicating  
the loss of a saccharide unit as in actinosporin A. The structure was determined as  
1,2,3-trihydroxy-3-(hydroxymethyl)-8-rhamnosyl-benz[α]anthracene-7,12-dione and assigned the 
trivial name actinosporin B.  
Figure 9. (A) Fragmentation of actinosporin B; (B) HMBC correlation of actinosporin B. 
Arrows are from proton (
1
H) to carbon (
13
C). 
 
 
(A) (B) 
Actinosporins A and B were tested against the parasites Leishmania major, Trypanosoma brucei brucei, 
and Plasmodium falciparum, and for cytotoxicity against J774.1 macrophages to verify the original 
activity of the extract. Antitrypanosomal activity after 48 and 72 h was detected for actinosporin A, 
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which exhibited IC50 values of 15.47 and 16.44 µM, respectively, with no cytotoxicity against J774.1 
macrophages (IC50 of >200 µM). However, actinosporin B was found to be inactive against T. brucei. 
Human African trypanosomiasis, also known as sleeping sickness, is a fatal disease caused by T. brucei 
affecting mostly the people living in tropical and subtropical regions of the world [46]. The increasing 
resistance to current therapies and the undesirable side-effects of existing drugs necessitates the 
development of new, safer, and more potent alternatives to combat this neglected disease. Natural 
products will continue to play a vital role in the search for new antitrypanosomal drugs [48,49]. 
3. Experimental Section  
3.1. Fermentation Approaches 
3.1.1. Solid Culture 
The Actinokineospora strain EG49 was fermented for 7 days at 30 °C on 10 ISP2 agar plates. 
Colonies and agar were cut into small pieces and macerated twice with 500 mL ethyl acetate under 
continuous shaking at 150 rpm (Edmund Bühler, Hechingen, Germany) overnight. Ethyl acetate marc 
was filtered (Whatman filter paper, Roth) and the combined filtrates (coded as Solid ethyl acetate) 
were dried with a rotary evaporator (Heidolph, Schwabach, Germany) under vacuum. The extracts 
were concentrated under vacuum and stored at 4 °C for chromatographic analysis. 
3.1.2. Liquid Culture 
One 2 L Erlenmeyer flask containing 1.5 L of ISP2 medium was inoculated with 1 mL of an 
exponentially growing five-day cell culture of Actinokineospora strain EG49 and kept in culture under 
shaking at 150 rpm and 30 °C for 7 days. After cultivation and filtration, the supernatant was extracted 
with ethyl acetate (2 × 750 mL). The cells were macerated in 500 mL methanol and shaken for 3 h  
(150 rpm), and subsequently filtered. The extracts (coded as Liquid ethyl acetate and Liquid methanol, 
respectively) were concentrated under vacuum and stored at 4 °C prior to further analytical and 
isolation work. 
3.1.3. Liquid Culture with XAD 
One 2 L Erlenmeyer flask containing 1.5 L of ISP2 medium supplemented with 20 g/L XAD-16 
(Sigma-Aldrich, Dorset, UK) was inoculated with 1 mL of an exponentially growing five-day cell 
culture of Actinokineospora strain EG49 and kept in culture under shaking at 150 rpm at 30 °C for 7 
days. After cultivation and filtration, the supernatant was extracted with ethyl acetate (2 × 750 mL). 
The cells and XAD were shaken with double volumes (2 × 750 mL) of acetone for 3 h, and 
subsequently filtered. The extracts (coded as XAD ethyl acetate and XAD acetone) were concentrated 
using a vacuum rotary evaporator and stored at 4 °C prior to analysis. Only cells grown in XAD resin 
were subject to acetone extraction. 
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3.1.4. Liquid Culture with Calcium Alginate Beads 
An exponentially growing five-day cell culture of Actinokineospora strain EG49 (500 mL) was 
collected by centrifugation at 7155× g for 10 min and the pellet was mixed with 4% (w/v) sodium 
alginate, containing HEPES buffer (1%). The sodium alginate mixture was slowly dropped with a  
5 mL syringe into a 1.5% (w/v) CaCl2 solution at 4 °C under stirring. The produced beads were washed 
three times with sterile distilled water. Three hundred mL calcium alginate beads with immobilized 
bacteria were transferred to a 2 L Erlenmeyer flask, containing 1.2 L ISP2 medium and incubated at  
30 °C under shaking (150 rpm) for 7 days. After filtration, the beads were extracted by shaking with 
methanol for 3 h, followed by filtration. The supernatant was extracted with ethyl acetate  
(2 × 750 mL). The extracts (coded as Beads ethyl acetate and Beads methanol) were concentrated 
under vacuum and stored at 4 °C prior to further analysis. Blank controls, devoid of bacteria, were 
used for each approach. The control liquid media were extracted only with ethyl acetate. 
3.2. General Procedure for Dereplication Study Using MS and NMR Data 
Extracts of 1 mg/mL in MeOH were analyzed in triplicates on an Accela HPLC (Thermo Fisher 
Fisher Scientific, Bremen, Germany), and detected at 280 and 360 nm with a a UV detector and an 
Exactive-Orbitrap high resolution mass spectrometer (Thermo Fisher Scientific, Bremen, Germany). 
Media blanks were prepared for comparison reasons. The HPLC column was an ACE (Hichrom 
Limited, Reading, UK) C18, 75 mm × 3.0 mm, 5 μm column. The mobile phase consisted of purified 
water (A) and acetonitrile (B) with 0.1% formic acid in each solvent. The gradient program started 
with 10% B and B was increased linearly in 30 min to 100% B at a flow rate of 300 µL/min and 
remained isocratic for 5 min before linearly decreasing in 1 min to 10% B. The column was then  
re-equilibrated with 10% B for 9 min before the next injection. The total analysis time for each sample 
was 45 min. The injection volume was 10 µL and the tray temperature was maintained at 12 °C. High 
resolution mass spectrometry was carried out in both positive and negative ESI ionization modes with 
a spray voltage of 4.5 kV and capillary temperature of 320 °C. The mass range was acquired from  
m/z 150 to 1500. 
Multi-fragmentation (MS
n
) experiments were accomplished for the negative ionization mode on an 
Orbitrap analyser, CID (The collision-induced dissociation) was utilized with a normalized collision 
energy of 35%, activation Q of 0.250 ms, and activation time of 30.000 ms applied on ions of most 
intense, 2nd most intense, and 3rd most intense peaks for MS
2
, MS
3
, and MS
4
, respectively at  
an isolation width of 3 microns with 5 microscans. Resolution was at 15,000 m/Δm50%, while the 
minimum ion signal threshold was set to 500. Fragment mass tolerance for molecular formula 
detection was set to ±5 ppm. 
Raw data were initially sliced into two data sets based on the ionization mode, using the 
MassConvert tool from ProteoWizard [50]. The sliced data sets were imported into MZmine2.10 [51]; 
a framework for differential analysis of mass spectrometry data. The high-resolution mass spectral 
(MS
1
) data set was deconvoluted and deisotoped, while mass adducts, fragments, as well as complexes 
were primarily identified and sorted with MZmine 2.10. The spectra were crop-filtered from 2 to  
35 min. The peaks in the samples and blanks were detected using the chromatogram builder. Mass ion 
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peaks were isolated with a centroid detector threshold that was greater than the noise level set to 1.0E4 
and an MS level of 1. Following this, the chromatogram builder was used with a minimum time span 
set to 0.2 min, and the minimum height and m/z tolerance to 1.0E4 and 0.001 m/z or 5.0 ppm, 
respectively. Chromatogram deconvolution was then performed to detect the individual peaks. The 
local minimum search algorithm (chromatographic threshold: 90%, search minimum in RT range:  
0.4 min, minimum relative height: 5%, minimum absolute height: 3.0E4, minimum ratio of peak 
top/edge: 2, and peak duration range: 0.3–5 min) was applied. Isotopes were also identified using the 
isotopic peaks grouper (m/z tolerance: 0.001 m/z or 5.0 ppm, retention time tolerance: 0.2 absolute (min), 
maximum charge: 2, and representative isotope: most intense). The retention time normalizer  
(m/z tolerance: 0.001 m/z or 5.0 ppm, retention time tolerance: 5.0 absolute (min), and minimum 
standard intensity: 5.0E3) was used to reduce inter-batch variation. The peak lists were all aligned 
using the join aligner parameters set to m/z tolerance: 0.001 m/z or 5.0 ppm, weight for m/z: 20, 
retention time tolerance: 5.0 relative (%), weight for RT: 20. Missing peaks were detected using the 
gap filling peak finder (intensity tolerance: 1.0%, m/z tolerance: 0.001 m/z or 5.0 ppm, and retention 
time tolerance of 0.5 absolute (min)). An adduct search was performed for Na-H, K-H, NH4, formate, 
and ACN + H (RT tolerance: 0.2 absolute (min), m/z tolerance: 0.001 m/z or 5.0 ppm, max relative 
adduct peak height: 30%). Additionally, a complex search was performed (ionization method:  
[M + H]
+
 for ESI positive mode and [M − H]− for ESI negative mode, retention time tolerance:  
0.2 absolute (min), m/z tolerance: 0.001 m/z or 5.0 ppm, and with maximum complex peak height of 
50%). The processed data set was then subjected to molecular formula prediction and peak 
identification. An accustomed library was created by employing an algorithm to use the molecular 
formula data set from Antibase
®
 (February 2012) and Marinlit
®
 (September 2012) from which the 
monoisotopic exact masses were recalculated. The accustomed library was used instead of the 
manually curated Antibase and MarinLit databases, which do not differentiate between monoisotopic, 
average, and most abundant mass. The created library was then coupled to MZmine and employed as 
the custom database for peak identification and dereplication. ―Hits‖ and unidentified peaks 
(Supplementary Tables S2, and Tables 1 and 2) were double checked against the MS raw data  
in Xcalibur 2.1. 
For NMR analysis, sample extracts as well as media blanks were prepared at a concentration of  
5 mg in 600 μL DMSO-d6. For the presaturation experiments, the water peak was suppressed and  
16 scans were recorded on a 400 MHz NMR system (JEOL, Tokyo, Japan), equipped with the 
40TH5AT/FG probe. 
Presaturation NMR spectra were processed using MestReNova (Mnova 8.1.0) software (Mestrelab 
Research, Santiago de Compostela, Spain). The spectral data of samples were stacked, superimposed, 
and normalized to a constant sum of 100, and each data point was set to be a fraction of the total 
integral [52]. Baseline correction was accomplished with Whittaker Smoother, apodized with Gaussian 
1.0, and smoothing done with Savitzy-Golay. The spectra were then binned, using a spectral width of 
0.04 ppm. The NMR and MS spectral data were converted to an ASCII text file and imported into 
Excel. The data was sorted and organized to remove background peaks that belonged to the culture 
media. For the NMR data, the solvent peak columns were also deleted. The sorted data was then 
exported to SIMCA 13.0.2 (Umetrics, Umeå, Sweden) to determine the significant production of unique 
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secondary metabolites between culture variables. Pareto scaling was used for both NMR and MS 
spectral data sets. PCA, HCA and supervised OPLS-DA were used to evaluate the best culture method. 
3.3. Purification of Actinosporins A and B 
Actinokineospora strain EG49 was fermented in 16 2 L-Erlenmeyer flasks, each containing 1 L of 
ISP2 medium at 30 °C for 7 days under shaking at 150 rpm. After 7 days of growth, the culture broth 
was filtered and extracted with 10 L ethyl acetate. The ethyl acetate extract was concentrated under 
reduced pressure and chromatographed on a silica gel column, and eluted with increasing ratios of 
MeOH in CHCl3 from 10% to 100%. The fraction (745 mg) collected with 40% MeOH was further 
fractionated by gel filtration on Sephadex LH-20 with increasing ratio of MeOH to yield fraction 2  
(83 mg) eluted at 60% MeOH in water. Finally, fraction 1 was purified on a semi-preparative HPLC 
system from Agilent (QuatPump G1311A, Degasser G1322A, Controller ALS G1313A, UV detector 
G1315A and Fraction collector G1364C). Acetonitrile (MeCN) and water buffered with 0.05% 
trifluoroacetic acid were used as solvents. Gradient elution with 10% to 100% MeCN in 20 min at a 
flow rate of 4 mL/min yielded the pure compounds 1 and 2 at a retention time of 7.3 and  
9.3 min, respectively. 
3.4. Compound Characterisation 
UV spectra were recorded on a Jasco V650 UV/vis spectrophotometer (Essex, UK), IR spectra were 
recorded on a Bruker Tensor 27 FT-IR spectrometer (Bremen, Germany). NMR spectra were recorded 
at 30 °C a Varian 600 MHz Unity INOVA spectrometer (Palo Alto, CA, USA) equipped with a triple 
resonance cold probe. The 
1
H and 
13
C NMR chemical shifts were referenced to the solvent peaks for 
CD3OD-d4 at δH 3.30 and δC 49.0, respectively. 
13
C NMR spectra were acquired using the Standard 
Varian s2pul Pulse Sequence. Spectrometer frequency was 150.81 MHz, number of scans used was 
5000, receiver gain at 30, relaxation delay set at 0.01 s. Spectral width at 37878.8 Hz. For HMBC 
experiments, pulse sequence gHMBCAD was used, number of scans was 16, receiver gain at 30, 
relaxation delay used was 0.8 s, spectral width was 9615.4 Hz for F2 and 33181.3 Hz for F1 with an 
acquired size of 2048 and 256 k, respectively. The average value for the 2 to 3 bond coupling constant 
was optimized to 8 Hz. For the HSQC-EDITED experiment, the pulse sequence gHSQC was used. 
Number of scans was 4, receiver gain at 30, relaxation delay at 1.0000. The average value of the one 
bond coupling constant was optimized at 140 Hz. 
The ROESYAD experiment was utilized to determine the stereochemistry of actinosporin A. 
However, NOESY experiments were performed for small molecules, at 600 MHz, and exhibited zero 
or very small NOEs at a range of mixing times. The ROESYAD experiment, on the other hand, did not 
show any TOCSY artifacts for the correlations in question. The mixing time used for the ROESY 
experiment was 400 ms. 
Actinosporin A (1): 3.8 mg of an orange amorphous powder;     
   +180 (c 0.002, MeOH);  
UV (MeOH): λmax (log ε) = 227 (4.41), 312 (4.06), 408 (3.61) nm; IR: 3389, 3206, 1677, 1644, 1625, 
1364 cm
−1
; 
1
H (CD3OD, 600 MHz), and 
13
C NMR (CD3OD, 125 MHz) data see Table 3; HR-ESIMS: 
found at m/z 613.1915 [M + H]
+
, calcd for C31H33O13, (613.1916), and at m/z 611.1768 [M − H]
−
, calcd 
for C31H31O13 (611.1770). 
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Actinosporin B (2): 0.8 mg of an orange amorphous powder;     
   +18.0 (c 0.05, MeOH); UV 
(MeOH): λmax (log ε) = 254 (4.41), 379 (4.06), 408 (3.61) nm; 
1
H NMR (CD3OD, 600 MHz) δH 7.96 
(1H, d, J11,10 7.4, H-11), 7.87 (1H, dd, J10,11 7.4, J10,9 8.2, H-10), 7.79 (1H, d, J5,6 7.8, H-5), 7.70 (1H, 
d, J9,10 8.2, H-9), 7.62 (1H, d, J6,5 7.8, H-6), 5.64 (1H, br s, H-1′), 4.93 (1H, bs, H-1), 4.83 (1H, d, 
J3A,3B 11.6, H-13A), 4.01 (2H, m, H-2 and H-2′), 3.51 (1H, m, H-5′) 3.33–3.53 (underneath HOD peak, 
H-13B, H-3′, H-4′), 3.01 (1H, d, J4A,4B 13.2, H-4A), 2.90 (d, J4B,4A 13.2, H-4B), 1.10 (3H, d, J6′,5′ 6.3, 
H-6′); 13C NMR (151 MHz, DMSO) δ = 181.0 (C-7), 156.9 (C-8), 140.7 (C-4a), 135.6 (C-11a), 133.27 
(C-6a), 133.31 (C-12a), 123.9 (C-7a), 122.0 (C-11), 116.0 (C-12b), 72.5 (C-13), 71.7 (C-3), 71.5  
(C-4′), 71.4 (C-3′), 70.5 (C-2′), 70.4 (C-2), 64.0 (C-5′), and 42.7 (C-4); HR-ESIMS: [M − H]− found  
at m/z 501.1402, calcd for C25H25O11 (501.1402); [M + H]
+
 found at m/z 503.1554, calcd for  
C25H27O11 (503.1548). 
3.5. Antitrypanosomal Activity Testing 
Antitrypanosomal activity was tested following the protocol of Huber and Koella [53]. Briefly,  
10
4
 trypanosomes per mL of the Trypanosoma brucei brucei strain TC 221 were cultivated in 
Complete Baltz Medium. Trypanosomes were tested in 96-well plate chambers against different 
concentrations of test substances at 0.25–40 µM in 1% DMSO to a final volume of 200 µL. For 
controls, 1% DMSO as well as parasites without any test compound were used simultanously in each 
plate to show that DMSO did not perturb the results. The plates were then incubated at 37 °C in an 
atmosphere of 5% CO2 for 24 h. After addition of 20 µL of Alamar Blue, the activity was measured 
after 48 and 72 h by light absorption using an MR 700 Microplate Reader (Dynatech Engineering Ltd., 
Willenhall, UK) at a wavelength of 550 nm with a reference wavelength of 650 nm The IC50 values of 
the test compound were quantified by linear interpolation of three independent measurements. 
3.6. Cytotoxicity Assay 
Macrophages (J774.1) were cultured in complete medium without phenol red in the absence  
or presence of increasing concentrations of the test compounds (0.25–200 µM) at a cell density of  
1 × 10
5
 cells/mL for 24 h, 37 °C, 5% CO2, and 95% humidity. Following the addition of 20 μL of 
Alamar Blue, the plates were incubated and the optical densities were determined after 48 and 72 h in 
the same manner as described for the anti-trypansomal assay, using a test wavelength of 540 nm and a 
reference wavelength of 630 nm. 
4. Conclusions 
Metabolomic profiling of Actinokineospora sp. EG49 crude extracts utilizing both high resolution 
mass spectrometry and nuclear magnetic resonance was employed to optimize culture conditions and 
extraction procedures. We conclude that ISP2 broth culture is more prolific and offers higher chemical 
diversity than the other three approaches employed in this study. With respect to the isolation of quinone 
analogues, ethyl acetate extraction of culture supernatants was superior to methanolic extraction of cell 
pellets. NMR and mass spectral data were successfully used as complementary tools to provide 
information about the known and the putative new compounds from EG49. Furthermore, actinosporins A 
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and B, new O-glycosylated angucyclines, were isolated from the sponge-derived Actinokineospora strain 
EG49. Actinosporin A exhibited activity against T. brucei brucei with an IC50 value of 15 µM. This is 
the first report on the isolation of angucycline derivatives from the genus Actinokineospora. 
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